XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
ISPC iSpecimen
- 1.860
- -0.090-4.62%
Close Feb 14 16:00 ET
- 1.853
- -0.007-0.39%
Post 19:43 ET
1.79MMarket Cap-0.10P/E (TTM)
1.960High1.860Low48.97KVolume1.950Open1.950Pre Close93.24KTurnover5.75%Turnover RatioLossP/E (Static)962.64KShares11.80052wk High0.38P/B1.58MFloat Cap1.76052wk Low--Dividend TTM850.99KShs Float579.598Historical High--Div YieldTTM5.13%Amplitude1.760Historical Low1.904Avg Price1Lot Size
About iSpecimen Company
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.
Company Profile
SymbolISPC
Company NameiSpecimen
Listing DateJun 17, 2021
Issue Price8.00
Founded2009
CEOMr. Robert Bradley Lim
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address8 Cabot Road,Suite 1800
CityWoburn
ProvinceMassachusetts
CountryUnited States of America
Zip Code01801
Phone1-781-301-6700
Websitehttp://www.ispecimen.com
Company Executives
- Name
- Position
- Salary
- Robert Bradley Lim
- Director, Chief Executive Officer, Treasurer and Secretary
- --
- Yuying Liang
- Chief Financial Officer
- --
- Katharyn Field
- Chairman of the Board
- --
- Richard Paolone
- Independent Director
- --
- John L. Brooks, III
- Independent Director
- 34.93K
- George Scholl
- Independent Director
- --
- Avtar Dhaliwal
- Independent Director
- --
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025